摘要 : When considering treatment options for patients with metastatic colorectal cancer (mCRC), molecular profiling has become a pivotal component in guiding clinical decisions. FOLFOX and FOLFIRI (fluorouracuil, leucovorin plus oxalipl... 展开
作者 | Deming~ Dustin A. Tran~ Nguyen H. Cavalcante~ Ludmila L. Lubner~ Sam J. Mulkerin~ Daniel L. LoConte~ Noelle K. Clipson~ Linda Matkowskyj~ Kristina A. |
---|---|
作者单位 | |
期刊名称 | 《Therapeutic advances in medical oncology》 |
总页数 | 11 |
语种/中图分类号 | 英语 / R45 |
关键词 | BRAF cetuximab KRAS NRAS panitumumab PIK3CA |
馆藏号 | N2010EPST0000657 |